I-lab2018 Bpifrance

Jul 23, 2018

Exeliom Biosciences is awarded I-Lab2018 from Bpifrance

Paris Biotech Santé

Sep 25, 2017

Exeliom Biosciences joins Paris Biotech Santé Incubator

Clinical Trial Live Biotherapeutics Crohn's Disease Belgium

Feb 24, 2022

Exeliom Biosciences announces approval of Clinical Trial Application from the Belgian Agency for Single Strain Live Biotherapeutic EXL01 (Faecalibacterium prausnitzii) for the treatment of Crohn’s Disease

Series-A Biotech Exeliom Biosciences Nextbiotix

Jul 5, 2018

Exeliom Biosciences (formerly Nextbiotix) raises €7 million to tackle inflammatory bowel diseases

contact

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.